🇺🇸 FDA
Pipeline program

Aliskiren

CSPP100A2408

Approved small_molecule completed

Quick answer

Aliskiren for Hypertension is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Pharmaceuticals
Indication
Hypertension
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials